Osteoporosis and cardiovascular diseases
Osteoporosis and cardiovascular diseases
Ang presyon ng dugo ay isa sa mga pangunahing indikasyon ng kalusugan, na hindi lamang sumasalamin sa puso at sistema ng sirkulasyon, kundi pati na rin sa aktibidad ng mga bato, mga organo ng endokrin, paggawa ng dugo, at ng sistema ng nerbiyos. Kaya naman, walang isang unibersal na gamot laban sa mataas na presyon ng dugo. Hindi ka basta basta puwedeng pumunta sa botika at magtanong ng 'tableta para sa presyon,' kasi agad na tatanungin ng parmasyutiko – anong gamot ang nireseta sa iyo ng doktor?
УЗНАТЬ ПОДРОБНЕЕ >>>
Osteoporosis and cardiovascular diseases: A neglected relationshipsIn recent years, the research increasingly with the connection between osteoporosis and cardiovascular disease (CVD). Although this disease, pictures appear to be at first glance completely different point epidemiological studies on common risk factors and pathophysiological mechanisms.Definition and epidemiologyOsteoporosis is a systemic skeletal disease that is characterized by a decrease in bone density and deterioration of bone architecture. This leads to an increased risk of fractures, particularly of the hip, spine, and forearm. Worldwide, about 200 million people are estimated to be affected by osteoporosis.Cardiovascular diseases include a variety of diseases of the heart and blood vessels, including coronary heart disease, heart attack, stroke, and vascular disease. CVD is the leading cause of death worldwide.Common Risk FactorsIn the analysis of the two disease groups, several common risk factors can be identified:Age: the risk for osteoporosis as well as for CVD increases significantly with age.Gender: women after the Menopause are due to the rapid drop in estrogen levels to an increased risk for osteoporosis; in addition, women in old age, a significantly increased risk for cardiovascular events.Style: Lack of physical activity, unhealthy diet, Smoking and excessive alcohol consumption life increase the risk for bone density loss as well as circulatory problems.Inflammation: Chronic low-threshold inflammatory processes play a role in the pathogenesis of both disease groups.Metabolic disorders: Diabetes mellitus, and metabolic syndrome are associated with an increased risk for osteoporosis as well as for CVD.Pathophysiological ConnectionsDieuchere research suggest that the Regulation of calcium and phosphate, which are important for bone homeostasis is of Central importance, also have a direct effect on the vessel wall and atherosclerosis development. In particular, the role of Vitamin D is intensively discussed: A deficiency of Vitamin D is associated with lower bone density and an increased risk for hypertension and congestive heart failure.In addition, studies show that the patients with osteoporosis often have an increased vascular stiffness and atherosclerosis. This could be due to common molecular pathways that control bone resorption as well as vascular calcification.Clinical ImplicationsThe recognisable link between osteoporosis and CVD has important clinical consequences:Early diagnosis: patients with the two diseases should be systematically for the Presence of the other investigated.Multidisciplinary care: The treatment should be interdisciplinary in nature, for example, through the cooperation of cardiologists, endocrinologists and orthopaedic surgeons.Style modification: health‑ promoting measures such as regular physical activity, a balanced diet with adequate calcium and Vitamin D content, as well as the lack of Smoking and excessive alcohol consumption can reduce the risk for both diseases.Drug therapy: Some of the medicines used for the treatment of osteoporosis, have shown promising effects on cardiovascular health, which needs to be further investigated.ConclusionThe connection between osteoporosis and cardiovascular disease is complex and multifactorial. The common risk factors and pathophysiological mechanisms suggest that an integrated prevention and treatment strategy is useful. Further research is necessary in order to understand the molecular basis of this Association and to develop innovative therapeutic approaches.Would you like me to make a certain section in more detail, or other aspects of adding?
Osteoporosis and cardiovascular diseases. Ginagamit ito bilang biologically active na pampadagdag sa pagkain — dagdag na pinagmumulan ng mga bitamina — B2, B6, C, mga organikong asido — mansanas, succinic, glutamine. Mga sangkap: malic acid, succinic acid, glutamic acid, badan extract, ascorbic acid, bitamina B2, B6.
Describe the main causes of cardiovascular diseases
Drink pills for high blood pressure
Levels of risk of cardiovascular diseases
Breathing exercises for high blood pressure
demo3.efesta.ru/articles/132648-arrhythmia-cardiovascular-disease-causes.html
mytube.by/articles/2441-cardiovascular-disease-doctor.html
Ginagamit ito bilang biologically active na pampadagdag sa pagkain — dagdag na pinagmumulan ng mga bitamina — B2, B6, C, mga organikong asido — mansanas, succinic, glutamine. Mga sangkap: malic acid, succinic acid, glutamic acid, badan extract, ascorbic acid, bitamina B2, B6. Kasabay nito, hindi inirerekomenda ang pangmatagalang pag-inom ng mga gamot mula sa kategoryang Diuretics, dahil ang mahahalagang sangkap tulad ng Potassium, Calcium, Magnesium ay mabilis na nailalabas sa katawan kasama ng sobrang tubig at asin. Alinsunod sa katangiang ito, sinasabayan ng mga Diuretics ang pag-inom ng mga gamot na may laman ng mga sangkap na ito. Maaaring ito ay mga vitamin at mineral na complexes, monokomponent, o mga suplemento sa pagkain na may napatunayang klinikal na bisa.
Of course! Here is a scientific Text on the subject in English, as:Tablets for the treatment of high blood pressure: the Suitability for a permanent applicationHypertension medical Arterial hypertension, is a widespread health problem that can lead for advanced development of significant complications — such as heart attack, stroke or kidney damage. An effective long-term therapy of diseases is therefore of Central importance for the prevention of this episode.Pharmacological basis of long-term treatmentFor the continuous lowering of blood pressure in different classes of Drug are available, which differ in their mechanisms of action and side-effect profiles. Among the most commonly used tablets for high blood pressure:ACE inhibitors (e.g., Enalapril, Ramipril): Inhibit the formation of Angiotensin II, which leads to a dilation of the blood vessels.AT1‑receptor blockers (such as Losartan, Valsartan): Block the action of Angiotensin II at the receptor.Calcium channel blockers (e.g., amlodipine, nifedipine): to Reduce the influx of Calcium into the smooth muscles of the vessel walls, which leads to a relaxation of the vessels.Beta-blockers (e.g., Metoprolol, Bisoprolol): Reduce the heart rate and cardiac output.Diuretics (eg, hydrochlorothiazide, furosemide): Promote the excretion of water and salt, which reduces the volume of blood.Criteria for Suitability for the duration of therapyFor a permanent application antihypertensive agents must meet the following criteria:Efficacy: The tablet must keep the blood pressure stable over the long term in the normal range (<140/90 mmHg, in patients at risk, often <130/80 mmHg).Compatibility: The side-effect profile should be as low as possible, to ensure the long-term compliance.Safety: long-term use may lead to organ damage, or other health risks.Easy dosing: a Single daily intake (Even tablets) increases the Compliance significantly.Cost-efficiency: Especially in the case of life-long intake of the cost structure plays a role.Study location and long-term dataSeveral large clinical studies (for example, ALLHAT, LIFE, ASCOT) have shown that ACE inhibitors, AT1‑receptor blockers and calcium channel blockers result in a favorable long-term prognosis in patients with hypertension. In particular, they reduce the risk of cardiovascular events by 20-30% in comparison to the placebo group.Also, the regulation of combination products (e.g., ACE inhibitor + diuretic) has proved to be effective and patient-friendly. These allow for a lower single-dose and thus reduce potential side effects.ConclusionMany of the tablets for the treatment of high blood pressure are suitable for a permanent application, provided that you meet the above criteria — efficacy, tolerability, safety, ease of dosing, and cost — efficiency. The individual choice of the drug should always be carried out under consideration of comorbidities, age, and life style of the patient. Regular monitoring of blood pressure and laboratory parameters is mandatory during long-term therapy, the therapy to optimally adapt and to identify possible adverse effects at an early stage.If you want, I can make certain sections in more detail, or other aspects (such as specific studies, adverse effects, or interactions) to add!